293 related articles for article (PubMed ID: 24073010)
1. Norcantharidin, derivative of cantharidin, for cancer stem cells.
Hsieh CH; Chao KS; Liao HF; Chen YJ
Evid Based Complement Alternat Med; 2013; 2013():838651. PubMed ID: 24073010
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.
Chen YJ; Kuo CD; Chen SH; Chen WJ; Huang WC; Chao KS; Liao HF
PLoS One; 2012; 7(5):e37006. PubMed ID: 22615870
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis.
Yun QS; Bao YX; Jiang JB; Guo Q
Pharmacol Rep; 2024 Apr; 76(2):263-272. PubMed ID: 38472637
[TBL] [Abstract][Full Text] [Related]
4. Targeting sonic hedgehog signaling by compounds and derivatives from natural products.
Huang YC; Chao KS; Liao HF; Chen YJ
Evid Based Complement Alternat Med; 2013; 2013():748587. PubMed ID: 23762158
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
Chen YJ; Chang WM; Liu YW; Lee CY; Jang YH; Kuo CD; Liao HF
Chem Biol Interact; 2009 Oct; 181(3):440-6. PubMed ID: 19616522
[TBL] [Abstract][Full Text] [Related]
7. Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin.
Ma Q; Feng Y; Deng K; Shao H; Sui T; Zhang X; Sun X; Jin L; Ma Z; Luo G
J Cancer; 2018; 9(12):2183-2190. PubMed ID: 29937938
[TBL] [Abstract][Full Text] [Related]
8. Medical uses of mylabris in ancient China and recent studies.
Wang GS
J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
[TBL] [Abstract][Full Text] [Related]
9. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
Yi SN; Wass J; Vincent P; Iland H
Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.
Chen YJ; Shieh CJ; Tsai TH; Kuo CD; Ho LT; Liu TY; Liao HF
Anticancer Drugs; 2005 Mar; 16(3):293-9. PubMed ID: 15711181
[TBL] [Abstract][Full Text] [Related]
12. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin.
Liu Q; Sun H; Li X; Sheng H; Zhu L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851
[TBL] [Abstract][Full Text] [Related]
13. Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance.
Ghandadi M; Valadan R; Mohammadi H; Akhtari J; Khodashenas S; Ashari S
Curr Pharm Des; 2019; 25(39):4192-4207. PubMed ID: 31721699
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells and tumorigenesis.
Zhu P; Fan Z
Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
[TBL] [Abstract][Full Text] [Related]
15. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years.
Zhou J; Ren Y; Tan L; Song X; Wang M; Li Y; Cao Z; Guo C
Biomed Pharmacother; 2020 Nov; 131():110755. PubMed ID: 33152920
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
[TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high/CD44high prostate cancer stem cells.
Acikgoz E; Mukhtarova G; Alpay A; Avci CB; Bagca BG; Oktem G
Mol Biol Rep; 2021 Apr; 48(4):3567-3578. PubMed ID: 33948856
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells.
Li X; Wang X; Xie C; Zhu J; Meng Y; Chen Y; Li Y; Jiang Y; Yang X; Wang S; Chen J; Zhang Q; Geng S; Wu J; Zhong C; Zhao Y
Anticancer Drugs; 2018 Mar; 29(3):208-215. PubMed ID: 29356693
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
20. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities.
Pan MS; Cao J; Fan YZ
Chin Med; 2020; 15():55. PubMed ID: 32514288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
